Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass
- 4 October 2019
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 59 (4) , 475-483
Abstract
Fat-free mass has gained wide acceptance as a scaler of the maintenance dose rate in obese patients. The choice of fat-free mass as a size scaler for the maintenance dose rate is based on its relationship with drug clearance, on the basis that only lean tissue is sufficiently metabolically active to provide capacity for elimination. For xenobiotics, the majority of biotransformation occurs in the liver and hence fat-free mass is implied to scale linearly with the component of liver that is metabolically active. The liver, like the body, can be assumed to comprise two components, lean mass and fat mass. We expect the lean liver mass (or volume) to be the component that most closely relates to drug clearance.Keywords
This publication has 56 references indexed in Scilit:
- Development and validation of anthropometric prediction equations for estimation of lean body mass and appendicular lean soft tissue in Indian men and womenJournal of Applied Physiology, 2013
- Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2013
- The Relationship between Drug Clearance and Body SizeClinical Pharmacokinetics, 2012
- Application of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese PatientsClinical Pharmacokinetics, 2011
- Lean Body Weight Scalar for the Anesthetic Induction Dose of Propofol in Morbidly Obese SubjectsAnesthesia & Analgesia, 2011
- Effect of Obesity on the Pharmacokinetics of Drugs in HumansClinical Pharmacokinetics, 2010
- Predictive Performance of the ‘Minto’ Remifentanil Pharmacokinetic Parameter Set in Morbidly Obese Patients Ensuing from a New Method for Calculating Lean Body MassClinical Pharmacokinetics, 2010
- Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studiesThe Lancet, 2009
- Quantification of Lean BodyweightClinical Pharmacokinetics, 2005
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974